Robert Honeywill

Long only
Robert Honeywill
Long only
Contributor since: 2013
3/6/15
Robert Honeywill
$SSH Assuming 20 enroll per qtr, suspension period of 40 days equates to 9 or 10 lost enrollments. Still screening so catch up is possible.
3/8/15
Robert, any thought as I am more concerned the future effect. Will any big company would jump in to help ? Will death be more in future
3/8/15
How death will be possible ? As SSH seemed that only 1 death happened in the past ? All four now... Kind of concern. Thanks Robert
3/6/15
Robert Honeywill
$SSH 4 non-device related deaths have no impact on safety or efficacy of C-Pulse.
12/8/14
Robert Honeywill
The Criticality Of Dividend Reinvestment Timing $JNJ http://seekingalpha.com/a/1mpod
11/30/14
Robert Honeywill
Thoratec: At The Heart Of A Health-Related Investment Strategy $THOR http://seekingalpha.com/a/1m9pn
11/25/14
Robert Honeywill
Johnson & Johnson Vs. BP: Ignore Dividend Growth Rate At Your Own Peril $JNJ, $BP http://seekingalpha.com/a/1m1yh
11/20/14
Robert Honeywill
Johnson & Johnson DGI Trumps Pure Income Vanguard Wellington Part II $JNJ http://seekingalpha.com/a/1lp8f
11/18/14
Robert Honeywill
Johnson & Johnson Part VII: 'Magic Pants' And 'Doubling Pennies' Continued $JNJ http://seekingalpha.com/a/1lmpl
11/15/14
Robert Honeywill
Johnson & Johnson Part VI: 'Magic Pants' And 'Doubling Pennies' $JNJ http://seekingalpha.com/a/1lhxx
11/13/14
Robert Honeywill
Johnson & Johnson DGI Trumps Pure Income Vanguard Wellington $JNJ http://seekingalpha.com/a/1lb1b
11/11/14
Robert Honeywill
Johnson & Johnson: Growth-Growth-Growth; Win-Win-Win - Part V $JNJ http://seekingalpha.com/a/1l427
10/25/14
Robert Honeywill
Johnson & Johnson: Growth-Growth-Growth; Win-Win-Win - Part IV $JNJ http://seekingalpha.com/a/1jnmz
10/18/14
Robert Honeywill
Johnson & Johnson: Growth-Growth-Growth; Win-Win-Win - Part III $JNJ http://seekingalpha.com/a/1j4lz
10/8/14
Robert Honeywill
Johnson & Johnson: Growth-Growth-Growth; Win-Win-Win - Part II $JNJ http://seekingalpha.com/a/1i9ph
10/1/14
Robert Honeywill
Johnson & Johnson: Growth-Growth-Growth; Win-Win-Win - Part I $JNJ http://seekingalpha.com/a/1i92p
9/12/14
Robert Honeywill
Novartis LCZ696: 'New Wonder Drug' OR 'Old Paradigm With Reduced Side Effects' $NVS http://seekingalpha.com/a/1hbp1
9/5/14
Robert Honeywill
Recent Developments Reaffirm Bright Prospects For Sunshine Heart's C-Pulse $SSH http://seekingalpha.com/a/1h0qb
8/11/14
Robert Honeywill
Sunshine Heart C-Pulse: A Paradigm Shift In Heart Failure Therapy $SSH http://seekingalpha.com/a/1fnc9
5/6/14
Robert Honeywill
Sunshine Heart: Turning Into A One Horse Race In The NYHA Class III Heart Failure Stakes $SSH http://seekingalpha.com/a/1b0nn
5/1/14
Robert Honeywill
Sunshine Heart: The 2 Horse Race For First In The NYHA Class III HF Stakes $SSH http://seekingalpha.com/a/1aqkl
4/30/14
Robert Honeywill
Sunshine Heart: Kimberley Olesen - A Big Fish From A Big Pond $SSH http://seekingalpha.com/a/1amup
Thanks Robert!
3/13/14
Robert Honeywill
Sunshine Heart: Unexpected Buying Opportunity $SSH http://seekingalpha.com/a/18q85
1/8/14
Robert Honeywill
Sunshine Heart: Potential '10 To 100 Bagger' Revisited - Part IV $SSH http://seekingalpha.com/a/15gyz
11/10/13
Robert Honeywill
SSH